02.06.20 ijBio Index
Infojet ClubijBio: Farm Involved ijBio-Index:
June,2 2020:
AstraZeneca (AZN) $54,7 (-1%)
Inovio (INO) $14,3 (-3.5%)
Moderna (MRNA) $59,8 (-3.7%)
Abbot (ABT) $92,6 (-0.4%)
Gilead (GILD). $73,3 (-2.5%)
Adaptive (ADPT) $38,8 (-0.6%)
CytoDyn (CYDY) $3 (0%)
AbbVie (ABBV) $91 (+0.4%)
Deciphera (DCPH) $59,3 (-2.3%)
Sorrento (SRNE) $4,8 (-4,6%)
At close 02.06.20=492,5 (-1,1%)
previous day <---> next day
At close 01.06.20= 498 (-0,62%)
At close 29.05.20= 501,4 (+3,8%)
At close 28.05.20=483 (+0,83)
Index was launched 26.05.20( 504)
--
Biosimilars of AbbVie’s Humira Have Saved Europe a Bundle, Study Says
Coronavirus update: Lockdowns, mass protests fuel debate over COVID spread, social justice
AbbVie Invests in a Cancer Drug - How to Trade the Stock
Should You Sell Abbott Laboratories Stock?
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ZM, SRNE and CLNY
Will Johnson & Johnson Acquire Arrowhead Pharmaceuticals?
These 2 charts show why record-high stock valuations shouldn’t worry investors
Gilead is developing inhaled remdesivir
Exclusive: Lonza sets new goal to make Moderna COVID-19 vaccine ingredients
Pfizer to invest up to $500 million in public drug developers
AbbVie Seeks US and EU Nods for Rinvoq for Psoriatic Arthritis
3 Pet Med Stocks That Offer Growth and a Nice Dividend
Inovio Analyst Watches Coronavirus Play 'From The Sidelines'
AbbVie Stock Affirmed Outperform at RBC on Allergan Potential
Gilead Down on Mixed Results From Coronavirus Drug Remdesivir
Gilead’s Drug Remdesivir Might Not Become the Standard Treatment Against Coronavirus, Analyst Says
Coronavirus Treatment Search Still on, Lilly, Gilead Give Updates
Forget Apple: Here Are 3 Better Dividend Stocks
AstraZeneca Ranked Most Inventive, Roche Most Innovative
Pfizer to invest up to $500 mln in public drug developers
AbbVie Stock Has Room to Run After Allergan Merger, Argus Says
The Zacks Analyst Blog Highlights: Pfizer
The Zacks Analyst Blog Highlights: Tencent, Abbvie and Reckitt Benckiser
Box, Ulta Beauty, Merck, Gilead and Johnson & Johnson highlighted as Zacks Bull and Bear of the Day
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Buy Lilly, AbbVie and Merck Stocks, J.P. Morgan Says, but Pfizer Is Still Expensive
Arcus Biosciences (RCUS) Catches Eye: Stock Jumps 5.4
Pfizer Embarks On $500 Million Investment Plan For Biotech Businessesgo
3 Stocks With Dividends Yielding More Than 3%
Gilead Unveils Mixed Data For Coronavirus Drug — Is GILD Stock A Buy?
Don’t Only Bet on Fast Vaccines, Root for Covid Treatments
ICU doctor warns: 'We could lose control of the virus again'
Coronavirus latest: Tuesday, June 2
Looting at Macy's, Target and other retailers is just one reason to avoid retail stocks
How He Made $2.8M Trading Stocks Part-Time At Home
Inequality & COVID-19 have created a powder keg across the country: Kansas City Mayor
Worried comments from Fed's Powell foreshadow even lower mortgage rates
California coronavirus infections spike as Gov. Newsom pushes forward with reopening plans
The Roku Channel expands to include over 100 live channels, adds a Live TV guide
Stock market news live updates: Stocks rise as reopening hopes offset concerns over ongoing protests
How civil unrest during the pandemic will change the election
© 2020 Verizon Media. All rights reserved.